Evidence map›Paper›PMID 38416704›Full record

ArticlePloS one2024

Risk factors contributing to infection with SARS-CoV-2 are modulated by sex.

Octavio A Lecona, América G Arroyo-Valerio, Nallely Bueno-Hernández, José Damian Carrillo-Ruíz, Luis Ruelas, René Márquez-Franco, Alejandro Aguado-García, Eira Valeria Barrón, Galileo Escobedo, Elizabeth Ibarra-Coronado and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Octavio A LeconaDoctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.ORCID 0000-0003-0098-7274
América G Arroyo-ValerioDirección de Investigación, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.ORCID 0000-0002-0404-0056
Nallely Bueno-HernándezDirección de Investigación, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
José Damian Carrillo-RuízDirección de Investigación, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
Luis RuelasDoctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.ORCID 0000-0003-0506-7741
René Márquez-FrancoDoctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Alejandro Aguado-GarcíaDirección de Investigación, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
Eira Valeria BarrónServicio de Medicina Genómica "Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
Galileo EscobedoDirección de Investigación, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
Elizabeth Ibarra-CoronadoCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Paola V Olguín-RodríguezCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Antonio Barajas-MartínezCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.ORCID 0000-0002-5299-0259
Ana Leonor RiveraCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.ORCID 0000-0002-0296-7966
Ruben FossionCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.ORCID 0000-0001-8456-2075
Universidad Autónoma de la Ciudad de México · MXHospital General de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout the early stages of the COVID-19 pandemic in Mexico (August-December 2020), we closely followed a cohort of n = 100 healthcare workers. These workers were initially seronegative for Immunoglobulin G (IgG) antibodies against SARS-CoV-2, the virus that causes COVID-19, and maintained close contact with patients afflicted by the disease. We explored the database of demographic, physiological and laboratory parameters of the cohort recorded at baseline to identify potential risk factors for infection with SARS-CoV-2 at a follow-up evaluation six months later. Given that susceptibility to infection may be a systemic rather than a local property, we hypothesized that a multivariate statistical analysis, such as MANOVA, may be an appropriate statistical approach. Our results indicate that susceptibility to infection with SARS-CoV-2 is modulated by sex. For men, different physiological states appear to exist that predispose to or protect against infection, whereas for women, we did not find evidence for divergent physiological states. Intriguingly, male participants who remained uninfected throughout the six-month observation period, had values for mean arterial pressure and waist-to-hip ratio that exceeded the normative reference range. We hypothesize that certain risk factors that worsen the outcome of COVID-19 disease, such as being overweight or having high blood pressure, may instead offer some protection against infection with SARS-CoV-2.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralFemaleHealth PersonnelHumansImmunoglobulin GMalePandemicsRisk FactorsAntibodies, ViralImmunoglobulin G

Identifiers

PMID38416704
PMCPMC10901358
OpenAlexW4392231176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.